Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer has appointed Michael Ehlers as chief scientific officer for Neuroscience Research. Mr Ehlers will report to Rod MacKenzie, senior vice president and head of PharmaTherapeutics R&D.
Subscribe to our email newsletter
Mr Ehlers most recently served as the George Barth Geller professor in the department of neurobiology at Duke University and as an investigator with the Howard Hughes Medical Institute. Previously he served as the director, Neuroproteomics Laboratory at Duke University.
Mr MacKenzie said: “Mike Ehlers’ experience in the field and his passion for transforming medical outcomes are a winning combination in helping Pfizer create the industry’s leading pipeline of neuroscience medicines.”
Mr Ehlers said: “I am excited to join an organisation that has a clear and focused commitment to neuroscience research. I look forward to bringing new insights and pushing forward these important areas of research in order to develop new medicines.”